Biotechnology General
BTG is a pioneering biopharmaceutical company founded in 1980, specializing in the development and manufacture of human health care products derived from genetic engineering and biotechnology processes. Now part of Ferring Pharmaceuticals, BTG operates a state-of-the-art cGMP biologics manufacturing facility and is committed to advancing healthcare through innovative biopharmaceuticals, with a focus on therapeutic areas such as reproductive health, endocrinology, orthopaedics, and ophthalmology.
Industries
Nr. of Employees
large (251-1000)
Products
Recombinant human growth hormone (somatropin)
Recombinant human growth hormone developed and manufactured for therapeutic use to treat growth hormone deficiency and related indications.
Recombinant follicle-stimulating hormone (follitropin delta) injection formulation
A human recombinant follicle-stimulating hormone provided as an injectable solution for controlled ovarian stimulation, supplied in cartridge format for use with an injection device.
Sodium hyaluronate intra-articular injectable
High-purity, high-molecular-weight sodium hyaluronate produced by microbial fermentation for intra-articular injection to support joint lubrication and pain reduction in osteoarthritis.
Sodium hyaluronate viscoelastic ophthalmic surgical aid
Fermentation-derived sodium hyaluronate formulated as a viscoelastic agent to maintain intraocular space and protect the corneal endothelium during cataract and other ophthalmic surgeries.
Regenesis
The world's first oral GLP-1 made by and delivered inside an edible microbe, provided as a single-dose daily powder.
Field-deployable biomanufacturing kits
Scaled-down biomanufacturing kits utilizing programmable microbes to synthesise precise molecules in austere environments.
Recombinant human growth hormone (somatropin)
Recombinant human growth hormone developed and manufactured for therapeutic use to treat growth hormone deficiency and related indications.
Recombinant follicle-stimulating hormone (follitropin delta) injection formulation
A human recombinant follicle-stimulating hormone provided as an injectable solution for controlled ovarian stimulation, supplied in cartridge format for use with an injection device.
Sodium hyaluronate intra-articular injectable
High-purity, high-molecular-weight sodium hyaluronate produced by microbial fermentation for intra-articular injection to support joint lubrication and pain reduction in osteoarthritis.
Sodium hyaluronate viscoelastic ophthalmic surgical aid
Fermentation-derived sodium hyaluronate formulated as a viscoelastic agent to maintain intraocular space and protect the corneal endothelium during cataract and other ophthalmic surgeries.
Regenesis
The world's first oral GLP-1 made by and delivered inside an edible microbe, provided as a single-dose daily powder.
Field-deployable biomanufacturing kits
Scaled-down biomanufacturing kits utilizing programmable microbes to synthesise precise molecules in austere environments.
Services
End-to-end contract services including process development, analytical method development and validation, technology transfer, and clinical/commercial manufacturing under cGMP.
End-to-end contract services including process development, analytical method development and validation, technology transfer, and clinical/commercial manufacturing under cGMP.
Expertise Areas
- Bioprocessing and biologics manufacturing
- Protein therapeutic development and purification
- Analytical method development and validation
- Regulatory affairs and global market approvals
Key Technologies
- Bacterial fermentation
- Mammalian cell culture
- Preparative and analytical chromatography
- Ultrafiltration / tangential flow filtration